LEADER 01457nam  2200385Ia 450 
001 9910699245503321
005 20230902161947.0
035   $a(CKB)5470000002401452
035   $a(OCoLC)488685012
035   $a(EXLCZ)995470000002401452
100   $a20091214d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eQ5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[1998]
215   $a1 online resource (i, 30 pages)
300   $a"ICH."
300   $a"September 1998."
517   $aGuidance for industry 
606   $aPharmaceutical biotechnology$zUnited States
606   $aBiological products$xEvaluation
615  0$aPharmaceutical biotechnology
615  0$aBiological products$xEvaluation.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699245503321
996   $aGuidance for industry$93434577
997   $aUNINA